We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.71%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.11B
AUM Growth
+$140M
(+4.7%)
Cap. Flow
-$15.5M
Cap. Flow
% of AUM
-0.5%
Top 10 Holdings %
Top 10 Hldgs %
31.89%
Holding
3,618
New
197
Increased
1,211
Reduced
1,199
Closed
259
Avg Time Held Equity + Options
3.7
years
Top 10 Avg Time Held Equity + Options
2.1
years
Top 20 Avg Time Held Equity + Options
2.5
years
Avg Time Held Equity only
3.7
years
Top 10 Avg Time Held Equity only
2.1
years
Top 20 Avg Time Held Equity only
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$72.4M |
| 2 |
iShares 10-20 Year Treasury Bond ETF
TLH
|
+$18.9M |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
+$9.7M |
| 4 |
iShares MSCI EAFE Growth ETF
EFG
|
+$3.85M |
| 5 |
Confluent
CFLT
|
+$3.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$39.5M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$19.1M |
| 3 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$18.1M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$16.4M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$7.99M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.46% |
| 2 | Technology | 15.44% |
| 3 | Healthcare | 8.51% |
| 4 | Financials | 6.64% |
| 5 | Consumer Discretionary | 4.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3201
Phibro Animal Health
PAHC
$1.54B
| $274 | ﹤0.01% |
20
-12
| -38% | -$172 |
2021 Q2
8 quarters
|
|
3202
AXIS Capital
AXS
$7.15B
| $269 | ﹤0.01% |
5
| – | – |
2022 Q4
2 quarters
|
|
3203
KraneShares Global Carbon Strategy ETF
KRBN
$137M
| $265 | ﹤0.01% |
+7
| New | +$272 |
2023 Q2
0 quarters
|
|
3204
Accel Entertainment
ACEL
$898M
| $264 | ﹤0.01% |
25
| – | – |
2022 Q2
4 quarters
|
|
3205
Planet Labs
PL
$5.29B
| $264 | ﹤0.01% |
+82
| New | +$325 |
2023 Q2
0 quarters
|
|
3206
Biohaven
BHVN
$1.73B
| $263 | ﹤0.01% |
11
| – | – |
2022 Q4
2 quarters
|
|
3207
DELISTED
Triumph Group
TGI
| $260 | ﹤0.01% |
21
-114
| -84% | -$1.3K |
2023 Q1
1 quarter
|
|
3208
Mesa Laboratories
MLAB
$715M
| $257 | ﹤0.01% |
2
| – | – |
2022 Q4
2 quarters
|
|
3209
DELISTED
Mersana Therapeutics
MRSN
| $257 | ﹤0.01% |
3
| – | – |
2022 Q2
4 quarters
|
|
3210
CALL
Microsoft
MSFT
$4.01T
| $257 | ﹤0.01% |
+800
| New | +$251K |
2023 Q2
0 quarters
|
|
3211
DELISTED
MidWestOne Financial Group
MOFG
| $256 | ﹤0.01% |
12
-532
| -98% | -$11.1K |
2021 Q1
9 quarters
|
|
3212
Tvardi Therapeutics
TVRD
$14.3M
| $252 | ﹤0.01% |
+2
| New | +$276 |
2022 Q1
5 quarters
|
|
3213
Filana Therapeutics
FLNA
$36.8M
| $245 | ﹤0.01% |
10
-23
| -70% | -$554 |
2021 Q1
9 quarters
|
|
3214
Green Dot
GDOT
$699M
| $244 | ﹤0.01% |
13
| – | – |
2022 Q4
2 quarters
|
|
3215
DELISTED
Enviva Inc.
EVA
| $239 | ﹤0.01% |
+22
| New | +$320 |
2023 Q2
0 quarters
|
|
3216
Amarin Corp
AMRN
$244M
| $238 | ﹤0.01% |
10
| – | – |
2018 Q4
18 quarters
|
|
3217
Teads Holding Co
TEAD
$40.8M
| $236 | ﹤0.01% |
48
| – | – |
2022 Q3
3 quarters
|
|
3218
Investar Holding Corp
ISTR
$395M
| $234 | ﹤0.01% |
19
-51
| -73% | -$625 |
2022 Q4
2 quarters
|
|
3219
DELISTED
The First Bancshares, Inc.
FBMS
| $233 | ﹤0.01% |
9
-292
| -97% | -$7.48K |
2020 Q4
10 quarters
|
|
3220
Dauch Corp
DCH
$1.21B
| $232 | ﹤0.01% |
28
| – | – |
2021 Q2
8 quarters
|
|
3221
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $232 | ﹤0.01% |
+5
| New | +$222 |
2023 Q2
0 quarters
|
|
3222
Invesco India ETF
IMVP
$94.6M
| $230 | ﹤0.01% |
10
| – | – |
2022 Q1
5 quarters
|
|
3223
Donnelley Financial Solutions
DFIN
$1.26B
| $228 | ﹤0.01% |
5
| – | – |
2022 Q1
5 quarters
|
|
|
CIO
3224
DELISTED
City Office REIT
CIO
| $223 | ﹤0.01% |
40
-2,524
| -98% | -$13.8K |
2022 Q1
5 quarters
|
|
|
LTCH
3225
DELISTED
Latch, Inc. Common Stock
LTCH
| $222 | ﹤0.01% |
160
| – | – |
2023 Q1
1 quarter
|
|
Similar funds
Parallel Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Parallel Advisors held 3,618 positions worth $3.11B, up 4.7% from $2.97B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Parallel Advisors's Q2 2023 filing shows 197 new, 1,211 increased, 1,199 reduced and 259 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K. The largest sale was Invesco S&P 500 Equal Weight ETF, an estimated $39.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 50% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2023 buy was JPMorgan Nasdaq Equity Premium Income ETF: 11,017 shares worth $533K.
- Parallel Advisors added most to iShares MSCI USA Quality Factor ETF in Q2 2023, an estimated $72.4M increase.
- Parallel Advisors's biggest Q2 2023 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $39.5M.
- Parallel Advisors fully exited Cvent Holding Corp. Common Stock in Q2 2023, selling an estimated $1.62M.
- Parallel Advisors's ten largest holdings make up 32% of its $3.11B portfolio in Q2 2023.
- Parallel Advisors opened 197 new positions and closed 259 in Q2 2023.
- Parallel Advisors's portfolio value rose 4.7% quarter-over-quarter to $3.11B.
Based on Parallel Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.